VIP

Trial Description: 
Phase II Study of Intravenous Vinorelbine in Patients With Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Fallopian Tube & Ovarian
Trial Status: 
Recruitment Pending
Contact person: